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Precarious Balance
Methylmercury, Selenium, and  
Cardiovascular Health
Inuit people living in Canada’s Nunavik region consume large 
doses of methylmercury through their traditional diet, mostly 
from sea mammal meat. A new study set out looking for evidence 
of links between these native communities’ exposure to the toxic 
metal and heart diseases [EHP 119(8):1077–1083; Ayotte et al.]. 
The results suggested an inhibitory effect of methylmercury on 
paraoxonase 1 (PON1), an enzyme whose activity may protect 
against cardiovascular problems. They also hinted unexpectedly 
that dietary nutrients, especially selenium, may counteract effects 
of methylmercury on PON1 activity. PON1 breaks down the oxi-
dized lipids that may promote atherosclerosis. 
The researchers collected blood plasma samples from nearly 
900 people living in about 500 households in different communi-
ties across Nunavik. Each person provided biological samples and 
completed surveys on their medical history, diet, and lifestyle habits. 
A simple correlation analysis indicated that higher blood 
mercury was associated with higher PON1 activity, contrary to 
findings from earlier in vitro studies. So the researchers turned to 
multivariate statistics to untangle other factors that might confound 
the mercury/PON1 relationship. These include intake of omega-3 
polyunsaturated fatty acids (n-3 PUFAs) and selenium, important 
nutrients provided by the traditional Inuit diet.
In the multivariate model, higher blood mercury levels were 
associated with decreased PON1 activity whereas higher blood levels 
of n-3 PUFAs and selenium were associated with increased PON1 
activity. The researchers also observed that PON1 activity decreased 
with age of participants, as previously reported in other populations.
Fish and sea mammal fats carry n-3 PUFAs that are beneficial 
for heart health, and have been known for some time to be a key 
nutrient in the traditional Inuit diet. This diet also includes such 
high-selenium foods as beluga whale muktuk (skin and fat). The 
researchers suggest that n-3 PUFAs and selenium in the Inuit diet 
may offset the inhibition of PON1 activity by methylmercury.
But as native populations shift to “modern” diets—for example, 
eating more fast food and prepackaged meals—the dietary balance 
between these nutrients and methylmercury could change, the 
researchers caution. For instance, if an individual consumes less 
dietary selenium, the negative effects of methylmercury may inten-
sify. The researchers emphasize that followup studies are necessary 
to monitor dietary changes and cardiovascular health among these 
Arctic communities.
Naomi Lubick is a freelance science writer based in Stockholm, Sweden, and Folsom, CA. She has 
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A Different Diabetes 
Arsenic Plus High-Fat Diet Yields an Unusual 
Diabetes Phenotype in Mice
Obesity is the leading cause of type 2 diabetes mellitus. Because inor-
ganic arsenic has been associated with type 2 diabetes in laboratory 
studies, chronic arsenic exposure has been hypothesized to heighten the 
risk of diabetes in obese individuals. A new study reveals a synergistic 
relationship between inorganic arsenic exposure and obesity that impairs 
glucose tolerance in mice [EHP 119(8):1104–1109; Paul et al.].
From age 4 weeks, male C57BL/6 mice, a strain susceptible to 
developing diet-induced diabetes, ate either a low- or high-fat diet 
and drank purified water (controls) or water with inorganic arsenic 
at 25 or 50 ppm. After 20 weeks, an oral glucose tolerance test was 
used to assess glucose homeostasis in the mice, and serum insulin 
was measured before and after glucose administration. Following 
sacrifice 7–10 days later, serum and tissue samples were collected 
to determine hydration, serum and hepatic triacylglycerol content, 
and body distribution of arsenic and arsenic metabolites. Statistical 
analysis focused on effects of diet, inorganic arsenic, and interactions 
between the two on the development of diabetes.
As expected, control mice on the high-fat diet weighed more and 
accumulated more fat than control mice on the low-fat diet. They 
exhibited higher fasting blood glucose, higher fasting and post–glucose 
challenge serum insulin, and greater insulin resistance, symptoms 
consistent with type 2 diabetes. In contrast, arsenic-exposed mice on 
the high-fat diet accumulated less fat than unexposed mice on the 
same diet and had lower serum triacylglycerol, fasting blood glucose, 
and insulin measures. However, glucose intolerance was high in these 
mice, even exceeding that observed in controls on the same diet.
The results suggest inorganic arsenic reduces diet-induced obesity 
in mice but acts synergistically with a high-fat diet to produce glucose 
intolerance, a symptom typically associated with prediabetes. The 
combination of glucose intolerance and elevated blood glucose levels 
with near-normal plasma insulin levels differs from the typical pheno-
type for type 2 diabetes.
The authors point out that the measures indicating near-normal insu-
lin sensitivity, when paired with glucose intolerance, can reflect impaired 
insulin production by pancreatic β cells—a characteristic of advanced 
diabetes. However, the study did not measure β cell function and signals 
that regulate it and thus cannot offer insight on this possibility. More 
comprehensive investigation is needed to determine how inorganic arsenic 
exposure, alone and with a high-fat diet, may induce type 2 diabetes.
Julia R. Barrett, MS, ELS, a Madison, WI–based science writer and editor, has written for 
EHP since 1996. She is a member of the National Association of Science Writers and the Board of 
Editors in the Life Sciences.
Beluga muktuk dries on racks 
at an Inuit whaling camp.